These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26374683)

  • 1. Gatekeepers for pragmatic clinical trials.
    Whicher DM; Miller JE; Dunham KM; Joffe S
    Clin Trials; 2015 Oct; 12(5):442-8. PubMed ID: 26374683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the ethical and regulatory issues in pragmatic clinical trials.
    Califf RM; Sugarman J
    Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical responsibilities toward indirect and collateral participants in pragmatic clinical trials.
    Smalley JB; Merritt MW; Al-Khatib SM; McCall D; Staman KL; Stepnowsky C
    Clin Trials; 2015 Oct; 12(5):476-84. PubMed ID: 26374687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.
    Lantos JD; Wendler D; Septimus E; Wahba S; Madigan R; Bliss G
    Clin Trials; 2015 Oct; 12(5):485-93. PubMed ID: 26374686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmonization and streamlining of research oversight for pragmatic clinical trials.
    O'Rourke PP; Carrithers J; Patrick-Lake B; Rice TW; Corsmo J; Hart R; Drezner MK; Lantos JD
    Clin Trials; 2015 Oct; 12(5):449-56. PubMed ID: 26374678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.
    Welch MJ; Lally R; Miller JE; Pittman S; Brodsky L; Caplan AL; Uhlenbrauck G; Louzao DM; Fischer JH; Wilfond B
    Clin Trials; 2015 Oct; 12(5):503-10. PubMed ID: 26374681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harms, benefits, and the nature of interventions in pragmatic clinical trials.
    Ali J; Andrews JE; Somkin CP; Rabinovich CE
    Clin Trials; 2015 Oct; 12(5):467-75. PubMed ID: 26374680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oversight on the borderline: Quality improvement and pragmatic research.
    Finkelstein JA; Brickman AL; Capron A; Ford DE; Gombosev A; Greene SM; Iafrate RP; Kolaczkowski L; Pallin SC; Pletcher MJ; Staman KL; Vazquez MA; Sugarman J
    Clin Trials; 2015 Oct; 12(5):457-66. PubMed ID: 26374685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.
    Tunis SR; Stryer DB; Clancy CM
    JAMA; 2003 Sep; 290(12):1624-32. PubMed ID: 14506122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems.
    Anderson ML; Califf RM; Sugarman J;
    Clin Trials; 2015 Jun; 12(3):276-86. PubMed ID: 25733677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing clinical evidence by proactively building quality into clinical trials.
    Meeker-O'Connell A; Glessner C; Behm M; Mulinde J; Roach N; Sweeney F; Tenaerts P; Landray MJ
    Clin Trials; 2016 Aug; 13(4):439-44. PubMed ID: 27098014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role and authority of gatekeepers in cluster randomized trials in health research?
    Gallo A; Weijer C; White A; Grimshaw JM; Boruch R; Brehaut JC; Donner A; Eccles MP; McRae AD; Saginur R; Zwarenstein M; Taljaard M
    Trials; 2012 Jul; 13():116. PubMed ID: 22834691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data monitoring committees for pragmatic clinical trials.
    Ellenberg SS; Culbertson R; Gillen DL; Goodman S; Schrandt S; Zirkle M
    Clin Trials; 2015 Oct; 12(5):530-6. PubMed ID: 26374679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatic clinical trials: ethical imperatives and opportunities.
    Kalkman S; van Thiel GJMW; Grobbee DE; van Delden JJM
    Drug Discov Today; 2018 Dec; 23(12):1919-1921. PubMed ID: 29906514
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical trial primer: historical perspective and modern implementation.
    Karsh LI
    Urol Oncol; 2012; 30(4 Suppl):S28-32. PubMed ID: 22795078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.
    Welsing PM; Oude Rengerink K; Collier S; Eckert L; van Smeden M; Ciaglia A; Nachbaur G; Trelle S; Taylor AJ; Egger M; Goetz I;
    J Clin Epidemiol; 2017 Oct; 90():99-107. PubMed ID: 28502810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the decision-making process for the selection of therapeutics to undergo clinical testing for spinal cord injury in the North American Clinical Trials Network.
    Guest J; Harrop JS; Aarabi B; Grossman RG; Fawcett JW; Fehlings MG; Tator CH
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):94-101. PubMed ID: 22985376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.